Letter
Effect of interferon alfa-2b and ribavirin treatment on hepatitis C–associated cryoglobulinemia and rheumatoid factor: Comment on the article by Vassilopoulos and Calabrese
First published: 04 February 2003
No abstract is available for this article.
REFERENCES
- 1
Vassilopoulos D,
Calabrese LH.
Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies.
Arthritis Rheum
2002;
46:
585–97.
- 2
Olsen NJ,
Jasin HE.
Decreased pokeweed mitogen–induced IgM and IgM rheumatoid factor synthesis in rheumatoid arthritis patients treated with gold sodium thiomalate or penicillamine.
Arthritis Rheum
1984;
27:
985–94.
- 3
Schvarcz R,
Yun ZB,
Sonnerborg A,
Weiland O.
Combined treatment with interferon alpha 2b and ribavirin for chronic hepatitis C in patients with a previous non response or non sustained response to interferon alone.
J Med Virol
1995;
46:
43–7.
- 4
Brillanti S,
Garson J,
Foli M,
Whitby K,
Deaville R,
Masci C, et al.
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.
Gastroenterology
1994;
107:
812–7.
- 5
Liang TJ,
Rehermann B,
Seeff LB,
Hoofnagle JH.
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
Ann Intern Med
2000;
132:
296–305.
- 6
Zuckerman E,
Keren D,
Slobodin G,
Rosner I,
Rozenbaum M,
Toubi E, et al.
Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon alpha.
J Rheumatol
2000;
27:
2172–8.
- 7
Calleja JL,
Albillos A,
Moreno-Otero R,
Rossi L,
Cacho G,
Domper F, et al.
Sustained response to interferon alpha or to interferon alpha plus ribavirin in hepatitis C virus associated mixed cryoglobulinemia.
Aliment Pharmacol Ther
1999;
13:
1179–86.
- 8
Clifford BD,
Donahue D,
Smith L,
Cable E,
Luttig B,
Manns M, et al.
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
Hepatology
1995;
21:
613–9.
